New 52 Week High Today

Protagonist Therapeutics Inc PTGX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 07/30/21 EDT
49.43UNCH (UNCH)
Volume
12,289
Close
49.43quote price arrow up+2.31 (+4.90%)
Volume
504,691
52 week range
14.16 - 49.50

...

Loading . . .
  • Open47.38
  • Day High49.50
  • Day Low47.38
  • Prev Close47.12
  • 52 Week High49.50
  • 52 Week High Date07/30/21
  • 52 Week Low14.16
  • 52 Week Low Date08/14/20

Key Stats

  • Market Cap2.323B
  • Shares Out46.99M
  • 10 Day Average Volume0.40M
  • Dividend-
  • Dividend Yield-
  • Beta1.56
  • YTD % Change145.19

KEY STATS

  • Open47.38
  • Day High49.50
  • Day Low47.38
  • Prev Close47.12
  • 52 Week High49.50
  • 52 Week High Date07/30/21
  • 52 Week Low14.16
  • 52 Week Low Date08/14/20
  • Market Cap2.323B
  • Shares Out46.99M
  • 10 Day Average Volume0.40M
  • Dividend-
  • Dividend Yield-
  • Beta1.56
  • YTD % Change145.19

RATIOS/PROFITABILITY

  • EPS (TTM)-1.82
  • P/E (TTM)-27.18
  • Fwd P/E (NTM)-20.43
  • EBITDA (MRQ)-68.088M
  • ROE (MRQ)-43.52%
  • Revenue (MRQ)31.17M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-224.79%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Protagonist Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company with a peptide technology platform focused on discovering and developing new chemical entities (NECs) to address significant unmet medical needs. The Company's product pipeline includes PTG-100, PTG-200 and PTG-300. Its primary focus is on developing oral peptide drugs that target biological pathways also targeted by marketed injectable antibody drugs. PTG-100 is an oral, alpha-4-beta-7 (a4b7)...
Harold Selick Ph.D.
Non-Executive Chairman
Dinesh Patel Ph.D.
President
Donald Kalkofen CPA
Chief Financial Officer
Address
7707 Gateway Blvd Ste 140
Newark, CA
94560-1160
United States

Top Peers

SYMBOLLASTCHG%CHG
RVNC
Revance Therapeutics Inc
29.08-0.16-0.55%
RVMD
Revolution Medicines Inc
28.64-0.46-1.58%
MORF
Morphic Holding Inc
57.62-1.98-3.32%
CYTK
Cytokinetics Inc
29.68+0.32+1.09%
ZNTL
Zentalis Pharmaceuticals Inc
53.21-1.41-2.58%